WolverHeme Happy Hour

35 Episodes

1. Episode 14: A Quantum Leap in AML Treatment? Dissecting Quizartinib Data with Dr. Dale Bixby

   Published: 9/05/2023
2. Episode 13: You get blinatumomab! You get blinatumomab!

   Published: 24/02/2023
3. Episode 12: Tinder for T Cells - Bispecifics in DLBCL

   Published: 8/02/2023
4. Episode 11: "Olu the Drunk Snowman" - IDH inhibitors in R/R AML with Dr. Jill Lykon

   Published: 21/01/2023
5. Episode 10: ASH Recap Part 2 - Papa Heme + WolverHeme

   Published: 21/12/2022
6. Episode 9: ASH Recap Part 1 - Dauno-Double Trouble

   Published: 14/12/2022
7. Episode 8: Pulling the Goalie on FLT3 Inhibitor Use in AML - A Discussion with Dr. Dale Bixby

   Published: 23/11/2022
8. Episode (3+)7: Straight Outta Roswell - OG AML Data

   Published: 7/10/2022
9. Episode 6: Dr. StrangeDrug or: How I Learned to Stop Worrying and Love the Asparaginase

   Published: 21/07/2022
10. Episode 5: IDH Inhibitors in AML: not so AGILE

    Published: 3/06/2022
11. Episode 4: All Aboard the Oncology StewardSHIP

    Published: 27/05/2022
12. Episode 3.2: Ranting About Rituximab in Acute Lymphoblastic Leukemia

    Published: 22/04/2022
13. Episode 3.1: History of Acute Lymphoblastic Leukemia Treatment and Building the BFM Backbone

    Published: 22/04/2022
14. Episode 2: We Don't Talk About Rylaze

    Published: 18/03/2022
15. Episode 1: Surrogate Endpoints in AML

    Published: 11/03/2022